Medy Tox Inc
KOSDAQ:086900
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medy Tox Inc
KOSDAQ:086900
|
KR |
|
Dhanlaxmi Bank Ltd
NSE:DHANBANK
|
IN |
|
Chongqing Zaisheng Technology Co Ltd
SSE:603601
|
CN |
|
Peninsula Energy Ltd
ASX:PEN
|
AU |
|
Animalcare Group PLC
LSE:ANCR
|
UK |
|
Aeroports de Paris SA
PAR:ADP
|
FR |
|
Better Life Commercial Chain Share Co Ltd
SZSE:002251
|
CN |
|
C
|
Chongqing Changjiang River Moulding Material Group Co Ltd
SZSE:001296
|
CN |
|
Eternal Materials Co Ltd
TWSE:1717
|
TW |
|
Indiabulls Housing Finance Ltd
NSE:IBULHSGFIN
|
IN |
|
Huazhu Group Ltd
HKEX:1179
|
CN |
|
C
|
China Smarter Energy Group Holdings Ltd
HKEX:1004
|
HK |
|
Al-Dawaa Medical Services Co
SAU:4163
|
SA |
|
Britannia Bulk Holdings Inc
OTC:BBLKF
|
UK |
|
I
|
Integer Holdings Corp
NYSE:ITGR
|
US |
|
Suzhou TZTEK Technology Co Ltd
SSE:688003
|
CN |
Discount Rate
Cost of Equity
Discount Rate
Medy Tox Inc's Cost of Equity, calculated using the formula Risk-Free Rate + Beta x ERP, stands at 8.4%. The Beta, indicating the stock's volatility relative to the market, is 1.18, while the current Risk-Free Rate, based on government bond yields, is 3.47%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
WACC
Discount Rate
Medy Tox Inc's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax. The WACC stands at 8.11%. This includes the cost of equity at 8.4%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 4.46%, reflecting the interest rate on Medy Tox Inc's debt adjusted for tax benefits. The weight of debt in the capital structure is 7.38%.
What is Medy Tox Inc's discount rate?
Medy Tox Inc 's current Cost of Equity is 8.4%, while its WACC stands at 8.11%. The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate."
How is Cost of Equity for Medy Tox Inc calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for Medy Tox Inc
How is WACC for Medy Tox Inc calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for Medy Tox Inc
